Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide

Background: In the present study we investigated the efficacy and tolerability of i.m. octreotide acetate (octreotide LAR) in patients with metastatic neuroendocrine tumors (NETs) previously treated and failed on i.m. lanreotide. Patients and methods: Fifteen patients (8 females, 7 males, median age...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of oncology 2000-09, Vol.11 (9), p.1127-1130
Hauptverfasser:	Ricci, S., Antonuzzo, A., Galli, L., Ferdeghini, M., Bodei, L., Orlandini, C., Conte, P. F.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Antineoplastic agents Antineoplastic Agents, Hormonal - therapeutic use Biological and medical sciences Biomarkers, Tumor - analysis Carcinoid Tumor - drug therapy Carcinoid Tumor - metabolism Chemotherapy Chromogranin A Chromogranins - urine Delayed-Action Preparations depot lanreotide Diarrhea - chemically induced Disease Progression Female Humans Hydroxyindoleacetic Acid - urine Intestinal Neoplasms - metabolism Intestinal Neoplasms - pathology LAR Liver Neoplasms - drug therapy Liver Neoplasms - metabolism Liver Neoplasms - secondary Lymph Nodes - pathology Male Medical sciences Middle Aged neuroendocrine tumors Neuroendocrine Tumors - drug therapy Neuroendocrine Tumors - metabolism Neuroendocrine Tumors - secondary octreotide Octreotide - therapeutic use Pancreatic Neoplasms - metabolism Pancreatic Neoplasms - pathology Peptides, Cyclic - therapeutic use Peritoneal Neoplasms - drug therapy Peritoneal Neoplasms - metabolism Peritoneal Neoplasms - secondary Pharmacology. Drug treatments Somatostatin - analogs & derivatives Somatostatin - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!